{"id":"W4390637832","doi":"10.1007/s12325-023-02719-3","title":"Intravitreal Aflibercept for Neovascular Age-Related Macular Degeneration Beyond One Year of Treatment: AZURE, a Randomized Trial of Treat-and-Extend vs. Fixed Dosing","year":2024,"lang":"en","type":"article","venue":"Advances in Therapy","topic":"Retinal Diseases and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"Bayer","keywords":"Aflibercept; Medicine; Macular degeneration; Dosing; Randomized controlled trial; Rheumatology; Ophthalmology; Bevacizumab; Internal medicine; Oncology; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001870327,0.0001917184,0.0008077084,0.0001535916,0.00002762895,0.00001871839,0.00003631829,0.00008371117,0.00003960888],"category_scores_gemma":[0.00003151592,0.0001333961,0.0003598127,0.0001889428,0.0001520753,0.0001351246,0.000005599184,0.00005061385,8.913923e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007292219,"about_ca_system_score_gemma":0.00005942836,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001161411,"about_ca_topic_score_gemma":0.00000807325,"domain_scores_codex":[0.9988354,0.0001073199,0.0004597755,0.0002795617,0.0001617424,0.00015619],"domain_scores_gemma":[0.9993824,0.000222689,0.0001057659,0.000182911,0.0000474776,0.00005877312],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.734322,0.001126683,0.0002253652,0.0002033327,0.001378803,0.00005360216,0.0008946393,0.000207431,0.005320774,0.003195912,0.000008949438,0.2530625],"study_design_scores_gemma":[0.9700779,0.005042784,0.0003604672,0.0003644699,0.001301963,0.000009571588,0.00005813108,0.002157862,0.01126221,0.007482462,0.001707255,0.0001749147],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9170246,0.07897902,0.0003732262,0.00009171558,0.0001607932,0.002653887,0.00005494531,0.00002888263,0.0006329626],"genre_scores_gemma":[0.9385076,0.05813062,0.00225565,0.00001779781,0.00009108083,0.0003183089,0.0002656093,0.00003475175,0.0003785672],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2528876,"threshold_uncertainty_score":0.5439736,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01396796621224704,"score_gpt":0.3149791968651613,"score_spread":0.3010112306529143,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}